Recruiting Pulmonary Embolism Studies in Linz
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, el...
About Pulmonary Embolism Clinical Trials in Linz
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Linz, . These studies are seeking a combined 303 participants. Research is being sponsored by Ipsen, argenx. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Linz — FAQ
Are there pulmonary embolism clinical trials in Linz?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Linz, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Linz?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Linz research site will contact you about next steps.
Are clinical trials in Linz free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Linz studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Linz are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov